February 15, 2017
February 15, 2017 —
A team of 18 University of California San Diego School of Medicine and Moores Cancer Center researchers has developed a new tool to analyze an often overlooked aspect of cancer genetics — an alteration that results in the loss or gain in a copy of a gene. This change, known as somatic copy-number alterations, may be key to disease progression and might offer new therapeutic approaches for ovarian cancer and other malignancies.
February 9, 2017
February 9, 2017 —
Think you have an idea that will change health care but need the means to bring your innovation to fruition? Register for UC Health Hack, a two-day interdisciplinary hackathon that will bring students, physicians, researchers, industry professionals and community members together to grapple with integrative medicine and global health issues in a fast-paced competition.
January 12, 2017
January 12, 2017 —
Since the summer of 2016, Cussen has spent 70 days in hospitals while being treated for leukemia. In November, he became the first inpatient at the newly opened Jacobs Medical Center at UC San Diego Health. Besides the floor-to-ceiling windows in all patient rooms, the new medical center allows patients to employ a combination of technologies not found at other California hospitals, moving inpatient care to a new level.
December 6, 2016
December 6, 2016 —
Patients at the newly opened Jacobs Medical Center at UC San Diego Health can be in command of their own experience by controlling room temperature, lighting, accessing their personal medical information, details on their patient care team and entertainment options all from their beds.
December 1, 2016
December 1, 2016 —
Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role for these enzymes in subduing cancer immunity. The findings could have a clinical role in improving efficiency of immunotherapy drugs.
November 15, 2016
November 15, 2016 —
A new bioinformatic framework developed by researchers at University of California San Diego School of Medicine has identified key proteins significantly altered at the gene-expression level in biopsied tissue from patients with diabetic kidney disease, a result that may reveal new therapeutic targets.
November 3, 2016
November 3, 2016 —
By removing the protein galectin-3 (Gal3), a team of investigators led by University of California School of Medicine researchers were able to reverse diabetic insulin resistance and glucose intolerance in mouse models of obesity and diabetes.
October 24, 2016
October 24, 2016 —
There are many unanswered questions about the mechanisms that contribute to the onset of type 1 diabetes. Researchers at University of California San Diego School of Medicine hope to answer some of them with two Type 1 Diabetes Special Statutory Funding Program grants from the National Institutes of Health totaling more than $5 million.
October 4, 2016
October 4, 2016 —
Physician-scientists with Moores Cancer Center at UC San Diego Health have been leading the way in pancreatic cancer care by investigating new therapies as well as offering innovative clinical trials and the latest treatments with a personalized medicine approach. This expertise led to the selection of Moores Cancer Center as one of 12 clinical trial sites for the Pancreatic Cancer Action Network’s newly created Precision Promise, the first large-scale precision medicine trial network designed to transform outcomes for patients with pancreatic cancer.
October 4, 2016
October 4, 2016 —
Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects.
